Nasdaq gains 2% in a bumpy week for Wall Street; Nvidia loses ~13%
at seekingalpha.com (Fri, 13-Nov 5:14 PM)
Moderna Chief Legal Officer Announces Retirement Agreement
at www.tipranks.com (Fri, 13-Nov 4:44 PM)
Evercore ISI Keeps Their Hold Rating on Moderna (MRNA)
at www.tipranks.com (Fri, 13-Nov 3:45 PM)
at www.tipranks.com (Fri, 13-Nov 12:45 PM)
Moderna Advances Updated mRNA Flu Vaccine Study as Investors Watch Pipeline Progress
at www.tipranks.com (Fri, 13-Nov 11:32 AM)
Moderna (MRNA) Gets a Sell from Citi
at www.tipranks.com (Fri, 13-Nov 9:37 AM)
Piper Sandler Reaffirms Their Buy Rating on Moderna (MRNA)
at www.tipranks.com (Fri, 13-Nov 9:07 AM)
Moderna preps Massachusetts facility as global supply site for cancer shot
at seekingalpha.com (Thu, 12-Nov 8:05 AM)
MSCI announces November index changes, adds Moderna to World Index
at seekingalpha.com (Thu, 12-Nov 5:12 AM)
Moderna Earnings Call Signals Growth and Oncology Momentum
at www.tipranks.com (Tue, 10-Nov 7:23 PM)
Stocks making big moves after hours: CRWV, STUB, LAND
at seekingalpha.com (Tue, 10-Nov 4:43 PM)
Moderna (MRNA) Receives a Hold from UBS
at www.tipranks.com (Mon, 9-Nov 8:55 AM)
Moderna’s mRNA-1469 earns WHO advisory recommendation for the DRC’s Tumaini Phase 2/3 Ebola study
Market Chameleon (Thu, 5-Nov 8:30 AM)
Moderna Earns a 12th Straight Top-Employer Ranking as 2026 Adds Two New Vaccine Approvals
Market Chameleon (Fri, 23-Oct 7:13 AM)
Moderna (MRNA) Highlights Operations Momentum With COO Appointment and Nasdaq-100 Addition
Market Chameleon (Thu, 15-Oct 7:10 AM)
Moderna Sets Nov. 6 Conference Call for Q3 2026 Results at 8:00 a.m. ET
Market Chameleon (Tue, 13-Oct 7:35 AM)
Moderna’s individualized mRNA cancer therapy hits a Phase 3 milestone alongside Merck’s Keytruda
Market Chameleon (Thu, 8-Oct 7:13 AM)
Moderna Set to Enter the Nasdaq-100 on Oct. 9, 2026, Replacing Warner Bros. Discovery
Market Chameleon (Fri, 2-Oct 7:13 AM)
Market Chameleon (Wed, 30-Sep 7:07 AM)
Market Chameleon (Tue, 22-Sep 11:46 AM)
Moderna Highlights Phase 3 Melanoma Data Slot at ESMO 2026, Sets Oct. 24 Investor Webcast
Market Chameleon (Tue, 22-Sep 7:29 AM)
Moderna spotlights Phase 3 melanoma data at ESMO 2026, setting up an October 24 investor webcast
Market Chameleon (Mon, 21-Sep 11:10 AM)
